716-881-8200
info@ahrminc.com
skip to the main content area of this page
News

AHRM Inc News


12
 
Epicept

Epicept press release.

10/26/2009 12:16:54 PM

' New Data Supports Pharmacoeconomic Benefits of Ceplene(R) TARRYTOWN, N.Y., Oct 26, 2009 (BUSINESS WIRE) -- Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announces the release of new findings demonstrating the pharmac'

Read More
Kinex announcement

AHRM Inc. joins with Kinex

10/7/2009 4:34:44 PM

'AHRM Inc. is pleased to announce that we have been awarded the CRO and data management responsibilities for Kinex's new Phase II KX2-391 study. The management of the study will be coordinated out of our Buffalo location. '

Read More
WBENC

AHRM Inc receives WBENC Certification

9/11/2009 12:25:22 PM

'AHRM Inc. is honored to have been approved and certified by WBENC. The WBENC certification for women owned businesses is one of the most widely recognized and respected certifications in the nation. Accepted by thousands of corporations within the country '

Read More
orius News

AHRM Inc. has secured a new project with Orius Innovations, LLC.

8/5/2009 10:11:22 AM

' Orius is a firm based upon the patented hands free automated tooth brushing technology, which requires little or no dexterity to operate and is designed to simultaneously clean a set of maxillary and mandible teeth in less than 40 seconds. Its use is pri'

Read More
Smartpill News News

AHRM Inc. joins with Smartpill

4/1/2009 9:36:12 AM

'AHRM Inc. is pleased to announce that we have been awarded the data management and monitoring responsibilities for the SmartPill Validation Study. The study will involve multiple facilities in the US as well as an additional site in the UK. The managemen'

Read More
12

Client Testimonial

"Experienced, flexible, reliable and professional: that is how I would describe them. The team planned well and communicated regularly. They worked with us in a collaborative manner to help us refine and achieve our goals. They are very responsive to requests. Even more importantly, staff is very personable and a joy to work with. Amy Hayward and her team cared very much about the success of the trial and wanted to help wherever they could. They demonstrate great enthusiasm and take full ownership in the success of the study. Even when questions are asked with very tight deadlines, or activities that are nearly out of scope, the team dives right in to help. All of these are characteristics I have found rare in other CROs. The team was a great pleasure to work with; I plan to work with them again and again."

Richard W. Berenson
Managing Director
Venzyme Venture Catalyst